ArticleAMB Express2025
Evaluation of extracts from Phyllostachys makinoi for their antibacterial and accelerated wound healing potential.
Article in AMB Express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Phyllostachys makinoi, an endemic bamboo species in Taiwan, is underutilized, despite its rich forest resources. Known for its antioxidant, anti-inflammatory, and antibacterial properties, this study explores the antimicrobial, anti-inflammatory, and wound-healing activities of P. makinoi extracts. The antibacterial potential of P. makinoi extracts was first evaluated using the agar diffusion method, along with minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) assays. Subsequently, electron microscopy and a conductivity meter were employed to assess whether P. makinoi extracts exert antibacterial effects by disrupting bacterial cell structures. Finally, the anti-inflammatory and cell proliferation-promoting effects of P. makinoi extracts were assessed in RAW264.7 and CCD-1112Sk cell models. The MIC and MBC of the P. makinoi water extracts against two multidrug-resistant Staphylococcus aureus strains were 4 and 16-32 mg/mL, respectively, while those for ethanol extracts were 2 and 32 mg/mL, respectively. In the time-kill assay, both strains were killed after treatment with extracts for 12 and 18 h. Scanning electron microscopy revealed that the bacterial cells treated with the extracts appeared rough, ruptured, and shriveled. The extracts disrupted the cell membranes, causing electrolyte, protein, and nucleic acid leakage, leading to cell death. Additionally, P. makinoi extracts reduced lipopolysaccharide-induced nitric oxide, tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 levels in RAW264.7 cells, and promoted wound healing by enhancing CCD-1112Sk cell proliferation. In conclusion, P. makinoi water and ethanol extracts demonstrated antibacterial and anti-inflammatory effects, showing potential for treating wound infections and accelerating healing, making them promising candidates for wound-healing therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.